Compare WVE & UNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | UNF |
|---|---|---|
| Founded | 2012 | 1936 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.6B |
| IPO Year | 2015 | N/A |
| Metric | WVE | UNF |
|---|---|---|
| Price | $15.74 | $193.35 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 16 | 4 |
| Target Price | $29.94 | ★ $174.75 |
| AVG Volume (30 Days) | ★ 13.7M | 278.0K |
| Earning Date | 11-10-2025 | 01-07-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 2.70 |
| EPS | N/A | ★ 7.98 |
| Revenue | $109,230,000.00 | ★ $2,432,352,000.00 |
| Revenue This Year | N/A | $3.19 |
| Revenue Next Year | $16.00 | $4.10 |
| P/E Ratio | ★ N/A | $24.26 |
| Revenue Growth | ★ 103.75 | 0.20 |
| 52 Week Low | $5.28 | $147.66 |
| 52 Week High | $21.73 | $243.70 |
| Indicator | WVE | UNF |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 64.42 |
| Support Level | $15.23 | $195.00 |
| Resistance Level | $18.50 | $199.98 |
| Average True Range (ATR) | 1.18 | 6.43 |
| MACD | -0.34 | 0.52 |
| Stochastic Oscillator | 16.51 | 51.98 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.